Were hiring a Senior Product Manager to take strategic ownership of live national-scale genomics products and shape the future of the Generation Study.
What were doing
The Generation Study is one of Genomics Englands most ambitious programmes - a national study exploring how whole genome sequencing can improve the diagnosis of rare genetic conditions in newborn babies and providing evidence to inform the governments future strategy on genomic newborn sequencing. Weve built the products that make it work and they are running at scale. Now we need someone to own them through the next - and arguably the most strategically interesting - phase of the study.
The Products
Youll take strategic ownership of three live products that form the operational backbone of the Generation Study:
The Generation Study Portal - the intake tool through which participants enter the study and which currently holds the contact demographics and consent information
The Bioinformatic Pipeline - the engine that processes whole genome sequencing data at scale and prioritises variants
The Variant Review Tool - the interpretation product used by clinicians to review genomic findings and generate reports for the NHS consultants
All three products are live and at a stable point in their lifecycle. Feature development is less intense now focused mainly on iterative changes that are critical to the continued success of mission. This role has an opportunity to spend some time looking ahead strategically and think carefully about what comes next.
The Squad
Youll be the Product Lead for the NII (Newborns Intake and Interpretation) Squad - a newly merged team that previously operated as three separate squads. The squad is fresh the ways of working are still being established and youll be working alongside a new squad coach who will handle day-to-day squad operations. This is a moment of real transition and the right person will find that energising rather than unsettling.
What makes this role unusual
The Generation Study is halfway through recruitment and will finish this early 2027 - what happens after that is genuinely open. It might mean evolving the products to support closedown of study processes followed by sunsetting and migrating their data capabilities into longer-lived Genomics England infrastructure. It might mean a managed lessons-learned process as the study concludes and understanding what components could transfer into a next phase. It might mean something more expansive: evolving these products into a new platform for APGP supporting a reanalysis of samples against a childhood panel or building remote consent capability for a new phase of the study. It could be elements of all of this.
We dont know yet. When we do know it will need to happen quickly and to a high standard.
We need someone who can hold the live products steady build trust with a newly merged squad and be ready to think and move strategically - in whichever direction the mission requires. Youll need to draw on resources across Genomics England spot and investigate parallels with other programmes and work out the best path forward from first principles when the time comes.
If that kind of strategic ambiguity sounds like an opportunity rather than a problem you are the kind of person we are looking for.
What youll be doing
Holding strategic ownership of the GSP bioinformatic pipeline and VRT - ensuring they run reliably and that any critical changes are well-considered and well-executed
Helping a newly merged squad find its feet - establishing shared ways of working alongside a new squad coach and creating the conditions for the team to do its best work
Staying close to the studys direction of travel building relationships across Genomics England and positioning the squad to move quickly when the path forward becomes clear
Thinking across possible futures - sunset migration evolution new capability - and being ready to develop and execute a credible strategy for whichever materialises
Managing stakeholders with clarity and confidence being transparent about priorities trade-offs and uncertainty
Mentoring and supporting team members and contributing to product management practice across Genomics England
What were looking for
Essential:
Experienced Senior Product Manager comfortable owning complex products in live production environments
Strategic thinker who can operate effectively under uncertainty and pivot when direction changes
Strong understanding of data products and backend systems - able to go deep with engineers when it matters
Excellent stakeholder management - able to hold credibility at senior levels while remaining genuinely collaborative
A natural connector - someone who seeks out parallels draws on expertise from across an organisation and builds the relationships needed to make things happen
Calm grounded and proactive - someone who figures things out rather than waiting to be told what to do
Experience leading and mentoring teams and creating collaborative environments where people do their best work
Preferred:
Experience managing product close-down migration or transition - including sunsetting products responsibly
Experience with complex data pipelines or bioinformatic / scientific software products
Scientific background - comfortable with biological or clinical language and engaging with genomics concepts
Prior genomics experience is not required. The focus is on strategic product management capability and the confidence to operate well in ambiguity.
Why this role
The Generation Study is asking whether genomic sequencing could become a routine part of newborn care - catching rare conditions earlier and changing outcomes for families. The products youll own are what make that possible right now at national scale.
As Senior Product Manager youll inherit live meaningful systems help a new team find its shape and play a genuine part in determining what the Generation Study leaves behind - for patients for the NHS and for the programmes that come after it.
Qualifications :
Youll have a demonstrable track record as a Senior Product Manager. While your qualifications provide a foundation were particularly interested in the breadth and depth of your experience as this gives a clearer picture of what you can bring to the role. Prior genomics experience is not required - the focus is on strategic product management capability and the confidence and experience to operate effectively in ambiguity.
Additional Information :
Salary From: 86100
Please note: This is a 1 Year FTC (Fixed Term Contract)
Closing Date: Monday 13th April at 23:00 (UK time)
Being an integral part of such a meaningful mission is extremely rewarding in itself but in order to support our people were continually improving our benefits package. We pride ourselves on investing in our people and supporting them to achieve their career goals as well as offering a benefits package including:
Equal opportunities and our commitment to a diverse and inclusive workplace
Genomics England is actively committed to providing and supporting an inclusive environment that promotes equity diversity and inclusion best practice both within our community and in any other area where we have influence. We are proud of our diverse community where everyone can come to work and feel welcomed and treated with respect regardless of any disability ethnicity gender gender identity religion sexual orientation or social background.
Genomics Englands policies of non-discrimination and equity and will be applied fairly to all people regardless of age disability gender identity or reassignment marital or civil partnership status being pregnant or recently becoming a parent race religion or beliefs sex or sexual orientation length of service whether full or part-time or employed under a permanent or a fixed-term contract or any other relevant factor.
Genomics England does not tolerate any form of discrimination harassment victimisation or bullying at work. Such behaviour undermines our mission and core values and diminishes the dignity respect and integrity of all parties. Our People policies outline our commitment to inclusivity.
We aim to remove barriers in our recruitment processes and to be flexible with our interview processes. Should you require any adjustments that may help you to fully participate in the recruitment process we encourage you to discuss this with us.
Culture
We have four key behaviours that represent what we would like Genomics England to feel like and the culture we want to encourage in order for us to achieve our mission. These behaviours help us all work well together deliver on our outcomes celebrate our successes and share feedback with each other. You can read about these and other aspects of our culture here Culture Genomics England
Blended working model
Genomics England operates a blended working model as we know our people appreciate the flexibility that hybrid working can bring. We expect most people to come into the office a minimum of 2 times each month. However this will vary according to role and will be agreed with your team leader. There is no expectation that people will return to the office full time unless they want to however some of our roles require full time on site attendance e.g. lab teams reception team.
Our teams and squads have and will continue to reflect on what works best for them to work together successfully and have the freedom to design working patterns to suit beyond the minimum. Our office locations are: Canary Wharf Cambridge and Leeds.
Onboarding background checks
As part of our recruitment process all successful candidates are subject to a Standard Disclosure and Barring Service (DBS) check. We therefore require applicants to disclose any previous offences at point of application as some unspent convictions may mean we are unable to proceed with your application due to the nature of our work in healthcare.
Remote Work :
No
Employment Type :
Full-time
Genomics England partners with the NHS to provide whole genome sequencing diagnostics. We also equip researchers to find the causes of disease and develop new treatments – with patients and participants at the heart of it all.Our mission is to continue refining, scaling, and evolving ... View more